v3.8.0.1

Quarterly Financial Data (Unaudited) | 12 Months Ended
--- | ---
Sep. 30, 2017
Quarterly Financial Information Disclosure [Abstract] |
Quarterly Financial Data (Unaudited) | 13. Quarterly Financial Data (Unaudited) The following is a summary of the unaudited quarterly results for the years ended September 30, 2017 and 2016 (in thousands, except per share data).
|  | First Quarter |  |  | Second Quarter |  |  | Third Quarter |  |  | Fourth Quarter |
Fiscal 2017 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total revenue |  | $ | 17,761 |  |  | $ | 17,503 |  |  | $ | 17,790 |  |  | $ | 20,058 |
Operating income |  |  | 3,268 |  |  |  | 1,677 |  |  |  | 1,743 |  |  |  | 415 |
Net income |  |  | 2,300 |  |  |  | 506 |  |  |  | 720 |  |  |  | 400 |
Basic net income per share (1): |  |  | 0.17 |  |  |  | 0.04 |  |  |  | 0.05 |  |  |  | 0.03 |
Diluted net income per share (1): |  |  | 0.17 |  |  |  | 0.04 |  |  |  | 0.05 |  |  |  | 0.03 |
Fiscal 2016 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total revenue |  | $ | 16,541 |  |  | $ | 16,699 |  |  | $ | 19,972 |  |  | $ | 18,154 |
Operating income |  |  | 3,939 |  |  |  | 2,240 |  |  |  | 6,597 |  |  |  | 4,083 |
Net income |  |  | 2,653 |  |  |  | 821 |  |  |  | 3,934 |  |  |  | 2,577 |
Basic net income per share (1): |  |  | 0.20 |  |  |  | 0.06 |  |  |  | 0.31 |  |  |  | 0.20 |
Diluted net income per share (1): |  |  | 0.20 |  |  |  | 0.06 |  |  |  | 0.30 |  |  |  | 0.20 |
| (1) | The sum of the quarterly income per share amounts may not equal the annual income per share total because of changes in the weighted average number of shares outstanding that occurred during the year.
In the fourth quarter of fiscal 2017, the Company recorded a $1.1 million license fee related to a customer’s acquisition and the Company’s sale of related jointly-owned intellectual property to the acquirer. In the first quarter of fiscal 2016, the Company recorded expense related to acquisition related costs, including due diligence and integration expenses of $2.5 million, related to the acquisitions of Creagh Medical and NorMedix (Note 3). During the second quarter of fiscal 2016, the Company recorded an out-of-period adjustment of $1.1 million to correct a cumulative overstatement of royalty revenue, of which $1.0 million related to years prior to fiscal 2016. The overstatement was evaluated and concluded to not be material to fiscal 2016, or any prior interim or annual periods. In the third quarter of fiscal 2016, the Company recorded a $2.9 million customer royalty catch-up payment related to periods prior to the third quarter fiscal 2016. In the fourth quarter of fiscal 2016, the Company recorded a $0.5 million reduction of the income tax provision related to the adoption of ASU 2016-09 as discussed in Note 9.

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -URI http://asc.fasb.org/topic&trid=2126967 + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration